D-0503-2024 Class II Terminated
FDA drug recall D-0503-2024 was initiated by American Regent, Inc. on May 14, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility. The recall status is terminated (terminated Dec 23, 2025). Affected quantity: 4,136 cartons (10 vials in each carton).
Recall details
- Product Type
- Drugs
- Report Date
- May 29, 2024
- Initiation Date
- May 14, 2024
- Termination Date
- Dec 23, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,136 cartons (10 vials in each carton)
Product description
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10
Reason for recall
Lack of Assurance of Sterility.
Distribution pattern
UT only
Code information
Lot #: 23087N0C0, Exp. Date 11/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0503-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026